HAKOP OGANYAN: Open Payments
NPI 1366472045 · NORTH HOLLYWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 11 payments from 7 companies in 2025. Trend: 2023 $1,167 · 2024 $2,300 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 2 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 1 | $45 |
| Alkermes, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: COBENFY, TRINTELLIX, SPRAVATO, UZEDY, VIVITROL, AUSTEDO XR, VRAYLAR, REXULTI.
Industry payments across CA — which companies pay providers there.
